[The experience of a biotechnology company for preclinical studies of drugs targeting cancer stem cells].

Autor:	Cairo S; XenTech, Genopole, Campus 3, 4, rue Pierre-Fontaine, 91000 Evry, France. Electronic address: Stefano.Cairo@xentech.eu., Jude JG; XenTech, Genopole, Campus 3, 4, rue Pierre-Fontaine, 91000 Evry, France.
Jazyk:	francouzština
Zdroj:	Bulletin du cancer [Bull Cancer] 2017 Dec; Vol. 104 (12), pp. 1094-1096. Date of Electronic Publication: 2017 Nov 21.
DOI:	10.1016/j.bulcan.2017.10.015
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu